Trial, No Error: Facilitating the Best Possible Outcome

May 17, 2017 – Clinical trials are inherently high risk and any errors can result in major disruptions or completely collapse the trail. It is extremely telling that only 12% of medicines in clinical trials make it to patients and, whilst there are many reasons that a trail could be unsuccessful, there is potential to mitigate some areas of risk and error.

View Full Article

Keeping Up With Compliance

May 17, 2017 – Regulatory affairs as an internal-company function encompasses a range of areas, but largely concerns the maintenance of already-approved drugs. Because filings vary slightly internationally and need to be harmonized at a global level to remain compliant, just keeping a license to sell, keeping it consistent and maintaining transparency is a huge task.

View Full Article

TrialScope solution reduces clinical trial disclosure non-compliance risks, costs

April 13, 2017 – ATLAS Global Compliance is a Software-as-a-Service (SaaS) solution that helps clinical trial sponsors to “disclose locally and comply globally,” says TrialScope CEO. According to the clinical trial transparency and compliance solutions provider, ATLAS Global Compliance enables sponsors to ensure trials are compliant by consolidating information from all trial sites into one view.

View Full Article

Putting the Patient Back into Clinical Trials

April 10, 2017 – The pharmaceutical industry is witnessing a deep shift in the traditional approach to patient disclosure in clinical trials. While most companies are struggling to meet basic compliance requirements, a longer-term objective has emerged that is shifting the transparency goal post.

View Full Article

AstraZeneca Strives For Greater Trial Transparency

March 22, 2017 – In February 2017, trial transparency provider TrialScope announced the launch of its Trial Results Summaries Portal that was developed in partnership with AstraZeneca. The Portal is a publicly accessible website where clinical trial sponsors can inform and educate trial participants and the general public about trial results in a non-promotional and non-biased venue.

View Full Article

Clinical Trial Transparency and the Perfect Storm

January 6, 2016 – I recently had the opportunity to host TrialScope’s Leadership Forum on Clinical Trial Transparency. The attendees, representing organizations that conduct global clinical trials, had come together to discuss pending changes to global transparency requirements, which will increase the scope of disclosure and shorten timelines.

View Full Article

Four Disclosure Compliance Risks that Clinical Trial Sponsors Should Identify and How to Avoid them


August 25, 2015
There are over 40 countries or regions with mandatory trial disclosure regulations and over 30 trial registries for posting clinical data. Few sponsors have evolved systems for continuous monitoring of trial disclosure and registry requirements. Thomas Wicks describes four practices that rise to the surface as major risks for trial sponsors regarding current and ongoing compliance.

View Full Article

Clinical Trial Transparency: The Stepping Stones To Disclosure

June 1, 2015 – Clinical Trial Disclosure is a complex compliance challenge that clinical trial sponsors around the world face every day. The complexity of managing dynamic clinical trial data and working with evolving health authority requirements on a global basis can be significant, and the sheer quantity of trials being conducted today only increases the complexity of this task.

View Full Article